HealthcareServices

Biomarker Testing Market Outlook 2026–2030: Key Business Drivers and Trends

February 20, 2026February 20, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the biomarker testing market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Biomarker Testing Market?

The biomarker testing market size has expanded rapidly in recent years. It is projected to grow from $19.75 billion in 2025 to $22.26 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.7%. The growth observed in the historic period is attributable to the increasing prevalence of chronic diseases, the expansion of clinical research activities, the rising adoption of molecular diagnostics, the growing demand for targeted therapies, and the availability of advanced testing platforms.

The biomarker testing market size is anticipated to undergo significant growth in the coming years. It is forecast to expand to $35.51 billion by 2030, driven by a compound annual growth rate (CAGR) of 12.4%. This expansion during the forecast period can be attributed to a surge in investments towards personalized medicine, the increasing application of biomarkers in the drug development process, the widening scope of oncology and infectious disease testing, a growing need for minimally invasive diagnostic tools, and ongoing advancements in multi-omics technologies. Key trends anticipated in this period include the increased adoption of precision medicine diagnostics, a rise in the use of companion diagnostics, the broader integration of AI in biomarker analysis, the expansion of liquid biopsy testing, and a greater emphasis on early disease detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24480&type=smp

What Drivers Are Supporting Technological Adoption In The Biomarker Testing Market?

The increasing prevalence of cancer is anticipated to fuel the expansion of the biomarker testing market. Cancer, a set of diseases defined by the uncontrolled proliferation and spread of abnormal cells in the body, is seeing a rise partly due to lifestyle choices such as poor diet, smoking, physical inactivity, and excessive alcohol consumption. Biomarker testing significantly improves cancer detection by enabling early and precise identification of disease-specific markers, thereby boosting diagnostic accuracy. It also supports personalized treatment plans, leading to enhanced patient outcomes and more effective healthcare management. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, around 165,000 new cancer cases were diagnosed in 2023, with projections indicating that approximately 204,000 cases will be diagnosed annually by 2033, contributing to an estimated total of 1.9 million cancer cases between 2024 and 2033. Consequently, the growing cancer burden is stimulating the growth of the biomarker testing market.

What Segment Types Are Examined In The Biomarker Testing Market?

The biomarker testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments, Services

2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, Immunoassays, Other Technologies

3) By Application: Oncology, Cardiology, Neurology, Infectious Diseases, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Consumables: Reagents, Assay Kits, Sample Collection Devices, Chemicals And Buffers

2) By Instruments: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Microarray Systems, Mass Spectrometry Instruments, Immunoassay Analyzers

3) By Services: Biomarker Discovery Services, Diagnostic Testing Services, Companion Diagnostic Development, Clinical Trial Testing Services, Contract Research Organization (CRO) Services

What Industry Trends Are Transforming The Biomarker Testing Market?

Major entities within the biomarker testing market are prioritizing the creation of technologically advanced solutions, such as immunohistochemistry (IHC) technology, with the goal of enhancing diagnostic precision, facilitating earlier disease identification, and underpinning personalized treatment approaches. Immunohistochemistry (IHC) technology itself functions as a laboratory technique, leveraging antibodies to pinpoint specific proteins within tissue samples, thereby aiding in the recognition and visualization of biomarkers essential for disease diagnosis and scientific investigation. As an illustration, in July 2023, Quest Diagnostics Incorporated, a US-based medical laboratories company, introduced a novel tissue-based prostate cancer biomarker test via its AmeriPath business. This launch was intended to elevate diagnostic accuracy by employing its unique biomarkers EV1, EV2, and EV3. This particular test fulfills a crucial clinical demand by empowering physicians to more accurately identify and distinguish aggressive forms of prostate cancer, leading to improved grading consistency and informing appropriate treatment strategies for patients.

Who Are The Major Companies Operating In The Biomarker Testing Market?

Major companies operating in the biomarker testing market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Hologic Inc., Charles River Laboratories International Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino Biological Inc., Proteome Sciences plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Biomarker Testing Market?

North America was the largest region in the biomarker testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Biomarker Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24480&type=smp

Browse Through More Reports Similar to the Global Biomarker Testing Market 2026, By The Business Research Company

Cancer Biomarker Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Clinical Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Biomarker Discovery Outsourcing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/biomarker-discovery-outsourcing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795